2. CARDIOVASCULAR SYSTEM

CARDIOVASCULAR SYSTEM: HYPERTENSION, ANGINA, MYOCARDIAL INFARCTION, HYPERLIPIDEMIA, AND CONGESTIVE HEART FAILURE: A TEACHER’S COMPREHENSIVE GUIDE

Welcome, future pharmacists and healthcare professionals!

Cardiovascular diseases (CVDs) are now the most common cause of death worldwide. They refer to a range of health conditions that affect the circulatory system, comprising the heart, arteries, veins, and capillaries. The treatment, symptoms, and prevention of these conditions often overlap. As a pharmacy educator with years of experience teaching pharmacotherapeutics, I have observed that students often find cardiovascular diseases challenging due to their complexity. Let me tell you: Understanding cardiovascular diseases is essential for every pharmacy professional.

In this comprehensive guide, I will walk you through the major cardiovascular diseases—hypertension, angina pectoris, myocardial infarction, hyperlipidemia, and congestive heart failure. I will explain their etiology, pathogenesis, clinical manifestations, and both non-pharmacological and pharmacological management. By the end of this article, you will have a thorough understanding of these critical conditions. Let us begin our journey!

Dpharmguru’s exam insights:

Cardiovascular diseases are frequently tested in pharmacy exams. Remember: Hypertension is defined as blood pressure above 120/80 mmHg. Angina is chest pain due to reduced blood flow to the heart. Myocardial infarction is a heart attack. Hyperlipidemia is high cholesterol levels. Congestive Heart Failure is the heart’s inability to pump enough blood. Pay special attention to the pharmacological management of each condition—these are almost always asked in exams!

HYPERTENSION

Hypertension or High Blood Pressure is a common long-term medical condition in which the blood pressure of the systemic artery increases beyond the normal pressure, i.e., 120/80 mmHg. Therefore, to deliver blood to tissues, the heart works harder to overcome the increased systemic pressure. This increased systemic arterial pressure puts strain on the heart and other arteries that result in high blood pressure.

Types of Hypertension

• Primary (Essential) Hypertension: Occurs when you have abnormally high blood pressure that is not the result of a medical condition. Often due to obesity, family history, and an unhealthy diet. Ranges from 130-139 mmHg systolic to 80-89 mmHg diastolic. Reversible with medications and lifestyle changes.
• Secondary Hypertension: Ranges from 140 mmHg or higher systolic and 90 mmHg or higher diastolic. High blood pressure results from other diseases, e.g., tumours (adrenal adenoma or pheochromocytoma), renal, endocrine, and cardiac disorders.

Etiology of Hypertension

Primary or Essential Hypertension

• Hyperactivity of sympathetic nerve stimulation
• Vasoconstriction due to release of vasoactive substances from endothelial cells
• Increase in cardiac output and arteriole constriction
• Excessive sodium intake, sodium retention, and hyper-insulinemia
• Family history of hypertension

Secondary or Non-essential Hypertension

• Congenital abnormalities
• Poly nephritis
• Obstruction in renal artery
• Acute or chronic glomerulonephritis
• Aortic stenosis
• Pheochromocytoma (tumours in adrenal gland)
• Cushing’s syndrome
• Hyperthyroidism
• Sleep apnoea
• Drugs such as NSAIDs, sympathomimetics, steroids, and antidepressants

Pathogenesis of Hypertension

Pathogenesis of essential hypertension is multifactorial and very complex. Kidneys are involved as the target organ of the hypertensive processes, and the disease involves interaction of multiple organ systems and numerous mechanisms of independent or interdependent pathways.

Hypertension can be explained by the following theories:

• Natriuretic Factors: Atrial Natriuretic Factor is secreted to promote salt excretion when the kidneys are unable to excrete sodium. The total peripheral resistance is increased as a side effect.
• Renin Angiotensin Aldosterone System (RAAS):
  • Renin Secretion: Low blood volume or low blood pressure detected by kidneys → kidney cells release renin
  • Angiotensinogen Conversion: Renin acts on angiotensinogen (produced by liver) → converts to Angiotensin I
  • ACE Activation: ACE in lungs converts Angiotensin I → Angiotensin II
  • Angiotensin II Effects: Potent vasoconstrictor → narrows blood vessels → increased peripheral resistance
  • Aldosterone Release: Angiotensin II stimulates aldosterone release from adrenal glands → promotes sodium and water reabsorption → increases blood volume and blood pressure
• Increased blood volume as well as vasoconstriction results in hypertension
• Stress response increases due to hyperactive sympathetic nervous system

Clinical Manifestations of Hypertension

• Severe headache
• Chest pain
• Blurred vision
• Bleeding from nose
• Difficulty in breathing
• Irregular heartbeat
• Nausea and vomiting
• Pain in neck and back
• Flushing
• Dizziness

Non-Pharmacological Management of Hypertension

• Dietary Changes: Low sodium and high potassium diet recommended
• Exercise: Physical activity like aerobics and cardio; proper weight management
• Stress Management: Exercises, meditation, or music
• Smoking Cessation: Smoking increases sympathetic nerve activity
• Alcohol Consumption: Moderate consumption lowers BP; limit to 2 drinks/day for men and 1 drink/day for women

Pharmacological Management of Hypertension

• Diuretics: Eliminate excessive sodium from the body. Examples: Indapamide, Hydrochlorothiazide, Chlorothiazide
• α-Blockers: Block action of norepinephrine; keep blood vessels open. Examples: Terazosin, Tamsulosin, Prazosin
• β-Blockers: Slow down heartbeat; less blood flow through veins. Examples: Propranolol, Metoprolol, Atenolol
• α+β-Blockers: Act like α-blockers but also slow heartbeat. Examples: Carvedilol, Labetalol, Dilevalol
• Calcium Channel Blockers: Block calcium entry into muscle cells; relax blood vessels. Examples: Amlodipine, Nifedipine, Diltiazem
• ACE Inhibitors: Relax and narrow blood vessels. Examples: Lisinopril, Enalapril, Captopril
• Angiotensin II Receptor Blockers (ARBs): Block angiotensin hormone; prevent narrowing of blood vessels. Examples: Valsartan, Losartan

Dpharmguru’s exam insights:

Pharmacological management of hypertension is frequently tested. Remember: ACE inhibitors end with “-pril” (Lisinopril, Enalapril, Captopril). ARBs end with “-sartan” (Valsartan, Losartan). β-Blockers end with “-olol” (Metoprolol, Atenolol, Propranolol). Calcium channel blockers include Amlodipine, Nifedipine, and Diltiazem. A common exam question is: “Which class of drugs ends with ‘-sartan’?” (Answer: ARBs).

ANGINA PECTORIS

Angina is a term used for chest pain caused by reduced blood flow to the heart muscles. It is a symptom of coronary artery disease and is typically described as squeezing, pressure, heaviness, tightness, or pain in the chest. Generally, it is an indication of coronary artery disease and a very strong sign that someone is at high risk of cardiac arrest, heart attack, and sudden cardiac death.

Types of Angina

• Stable/Chronic Angina: Occurs when the heart is working harder than normal. Follows a regular pattern. Symptoms relieved by rest or medication.
• Unstable Angina: Does not follow a regular pattern; can occur at rest. More serious; rest or medication is not enough for relief.
• Microvascular Angina: Affects the heart’s smallest coronary artery blood vessels. Can occur during daily activities or stress. Lasts longer (10-30 minutes).
• Variant (Prinzmetal) Angina: Caused by coronary spasms. Commonly occurs at night. Triggered by substance use disorder, smoking, cold weather, certain medications, and stress.

Etiology of Angina

• Coronary artery diseases (most common cause)
• Coronary artery spasm
• Diabetes, elevated cholesterol, high blood pressure, and smoking
• Exercise, stress, and thyrotoxicosis (increased cardiac output required)
• Aortic stenosis (increased cardiac output needed)
• Hypertension (peripheral vascular resistance increased)

Pathogenesis of Angina

Atherosclerosis is the most common cause of angina. Angina is almost always related to substantial blockage of at least one major coronary artery. To meet its constant needs, the myocardium obtains a substantial amount of oxygen from coronary circulation. When a coronary artery is blocked, blood flow cannot be increased, resulting in ischemia.

Anginal pain is caused by:

• Physical activity increasing myocardial oxygen demand
• Exposure to cold causing vasoconstriction and higher blood pressure
• Consuming a large meal shunting blood for digestion, lowering blood supply to heart muscle
• Stress or emotional conditions causing catecholamine release

Clinical Manifestations of Angina

• Severe headache
• Chest pain
• Dizziness
• Difficulty in breathing
• Nausea
• Vomiting
• Blurred vision or other vision changes
• Anxiety

Non-Pharmacological Management of Angina

• Quit smoking
• Controlling weight
• Regular check-up of cholesterol levels
• Rest and slow down
• Avoiding heavy meals
• Avoiding stress efficiently
• Adding fruits, vegetables, whole grains, low-fat dairy, lean meat, and fish in diet

Pharmacological Management of Angina

• Nitrates: Nitroglycerin (sublingual spray or tablet) rapidly relieves anginal pain by opening coronary arteries
• β-Blockers: Decrease blood pressure and slow heart rate. Examples: Metoprolol, Bisoprolol
• Calcium Channel Blockers: Decrease blood pressure and slow heart rate. Examples: Nifedipine, Verapamil, Diltiazem
• Antiplatelet Drugs: Prevent formation of blood clots. Examples: Clopidogrel, Prasugrel

MYOCARDIAL INFARCTION (MI)

Myocardial Infarction or a heart attack is a condition in which the blood flow to a part of the heart stops or is highly inadequate, causing that part of heart muscle to die and fail to pump blood. This can disrupt the pumping sequence of the entire heart, thus blood flow to the rest of the body reduces or may even stop, proving to be fatal if not treated immediately.

Types of MI

• Type 1: Ischemia caused by a primary coronary event (plaque rupture, thrombotic occlusion)
• Type 2: Secondary to ischemia caused by supply and demand mismatch
• Type 3: Results in sudden cardiac death
• Type 4: MI associated with percutaneous coronary intervention (type 4a) or in-stent thrombosis (type 4b)
• Type 5: MI associated with coronary artery bypass surgery

Etiology of MI

• Rupture of an atherosclerotic plaque within a coronary artery
• Arterial spasm and thrombus formation
• Ventricular hypertrophy
• Coronary artery vasospasm
• Hypoxia (due to carbon monoxide poisoning or acute pulmonary disorders)
• Arteritis
• Coronary artery emboli
• Drugs such as Cocaine, amphetamines, and ephedrine poisoning
• Coronary anomalies
• Aortic dissection with retrograde involvement of coronary artery

Pathogenesis of MI

Coronary artery thrombosis is the cause of most acute types of myocardial infarction. The underlying atherosclerotic plaque gets disrupted (e.g., fissure formation) that serves as a stimulus to generate the thrombus in most cases.

Within 20-30 minutes of coronary artery occlusion, myocardial necrosis starts. The sub-endocardial region of the myocardium is the most poorly perfused region. Myocardial infarcts typically start in the sub-endocardial region because of increased weakness due to ischemic injury. Within 3-6 hours, the infarcts reach their maximum extent.

Clinical Manifestations of MI

• Sudden chest pain (radiating to the left arm or left side of the neck)
• Shortness of breath
• Anxiety
• Sweating
• Palpitations or tremors
• Nausea and vomiting

In females: Weakness, shortness of breath, fatigue, and feeling of indigestion are observed.

Non-Pharmacological Management of MI

• Smoking Cessation: Prioritise when reducing risk factors
• Diet: Replace saturated and trans-fatty acids with unsaturated fats (olive oil, canola oil, avocados, almonds). Balanced diet high in vegetables and legumes, low in meat, low in dairy, daily consumption of nuts and olive oil
• Body Weight: Measure waist circumference and calculate BMI
• Physical Activity: Regular physical activity lowers the risk of cardiovascular disease and mortality

Pharmacological Management of MI

• Blood Thinners (Aspirin): Break blood clots to resume normal blood flow
• Thrombolytics (Streptokinase): Dissolve clots
• Antiplatelet Drugs (Clopidogrel): Prevent formation of new clots
• Nitroglycerine: Widens blood vessels
• β-Blockers (Carvedilol): Lower blood pressure and relax heart muscles
• ACE Inhibitors (Enalapril): Lower blood pressure and reduce stress on heart
• Pain Relievers (Morphine): Relieve discomfort

HYPERLIPIDEMIA

Hyperlipidemia is a condition in which the levels of fats (lipids) in blood, including cholesterol and triglycerides, increases abnormally. Although hyperlipidemia is hereditary, it is most commonly caused by lifestyle factors (poor diet and insufficient physical activity).

Normal Cholesterol Levels

Etiology of Hyperlipidemia

• Smoking
• Excessive alcohol consumption
• Consuming foods high in saturated or trans-fats
• Being inactive and spending most of the time sitting
• Being stressed
• Inheriting genes that make cholesterol levels unhealthy
• Obesity

Pathogenesis of Hyperlipidemia

Cholesterol is a type of fat that travels through the bloodstream in lipoprotein vehicles:

• Low-Density Lipoprotein (LDL) or Bad Cholesterol: Can block arteries. Borderline high: 130-159 mg/dL; High: 160-189 mg/dL
• Very Low-Density Lipoprotein (VLDL): Bad cholesterol that transports triglycerides contributing to arterial plaque formation
• High-Density Lipoprotein (HDL) or Good Cholesterol: Transports cholesterol to the liver for elimination. An HDL level of <40 mg/dL is undesirable

Clinical Manifestations of Hyperlipidemia

• Most people remain asymptomatic
• Xanthomas: Waxy, fatty plaques on the skin
• Corneal Arcus: Cholesterol rings around the iris

Non-Pharmacological Management of Hyperlipidemia

• Exercising
• Quitting smoking
• Limiting alcohol consumption
• Getting at least 7 hours of sleep every night
• Keeping stress under control
• Consuming nutritious foods
• Losing a few pounds to achieve a healthy weight

Pharmacological Management of Hyperlipidemia

• Statins: Prevent liver from producing cholesterol. Examples: Rosuvastatin, Atorvastatin
• Cholesterol Absorption Inhibitors: Prevent cholesterol absorption from intestine. Example: Ezetimibe
• Nicotinic Acid: Affects lipid production in the liver; reduces LDL and triglycerides, increases HDL
• Fibrates: Lower triglycerides and may raise HDL. Examples: Fibrates
• Resins: Bind to bile and prevent it from doing its role; liver needs more cholesterol to produce bile

CONGESTIVE HEART FAILURE (CHF)

Congestive Heart Failure is a condition in which the heart fails to pump blood in a quantity sufficient to fulfil the body requirements. Narrowed heart arteries (coronary artery disease) or high blood pressure make the heart too weak or stiff to fill and pump efficiently.

Types of CHF

• Left-Sided Heart Failure: Fluid back-up in the lungs, causing shortness of breath
• Right-Sided Heart Failure: Fluid back-up in the abdomen, legs, and feet, causing swelling
• Systolic Heart Failure: Left ventricle fails to contract vigorously (pumping problem)
• Diastolic Heart Failure: Left ventricle fails to relax or fill completely (filling problem)

Etiology of CHF

• Narrowing of arteries supplying blood to the heart muscles (coronary artery disease)
• Previous myocardial infarction or heart attack
• Congenital heart defects
• Endocarditis (infection in heart valve) or myocarditis (infection in heart muscles)
• Heart valve disease (due to past rheumatic fever or other causes)
• High blood pressure for long-term
• Cardiomyopathy (disease of the heart muscles)

Stages of Heart Failure

• Stage A: High risk of developing heart failure, but no symptoms or abnormalities
• Stage B: Alterations in cardiac function, but no symptoms. Ejection fraction may be lower than normal
• Stage C: Diminished heart function and current or previous heart failure symptoms
• Stage D: Persistent heart failure symptoms; ejection fraction drops significantly

Clinical Manifestations of CHF

• Breathing problems
• Tiredness and weakness in legs when active
• Swollen ankle, leg, and abdomen
• Weight gain
• Urge to urinate at night
• Palpitations (rapid or irregular heartbeats)
• Dry, hacking cough
• Bloated or hard stomach, appetite loss, or nausea

Non-Pharmacological Management of CHF

• Diet: Suitable general nutrition and weight loss in obese patients. Avoid high-salt foods
• Fluid: Limit fluid intake in patients who are overloaded or have severe CHF
• Lifestyle modifications: Limit alcohol consumption, avoid smoking
• Exercise: Encourage regular exercise

Pharmacological Management of CHF

• ACE Inhibitors: Dilate blood vessels, ease blood flow. Examples: Captopril, Enalapril, Quinapril
• β-Blockers: Slow heart rate, reduce oxygen demand. Examples: Bisoprolol, Carvedilol, Metoprolol
• Diuretics: Reduce fluid in the body
  • Loop Diuretics: Enhance urine production. Examples: Furosemide, Ethacrynic acid, Torsemide
  • Potassium-sparing Diuretics: Eliminate fluid and salt while retaining potassium. Examples: Triamterene, Eplerenone, Spironolactone
  • Thiazide Diuretics: Expand blood vessels, expel excess fluid. Examples: Metolazone, Indapamide, Hydrochlorothiazide

Dpharmguru’s exam insights:

Congestive Heart Failure is frequently tested. Remember: CHF has four stages—A, B, C, and D. The pharmacological management includes ACE inhibitors, β-Blockers, and Diuretics. Loop diuretics (Furosemide) are commonly used for fluid removal. A common exam question is: “What is the difference between systolic and diastolic heart failure?” (Answer: Systolic is a pumping problem; diastolic is a filling problem).

COMPARISON: CARDIOVASCULAR DISEASES

FREQUENTLY ASKED QUESTIONS (FAQs)

1. What is the normal blood pressure range?

The normal blood pressure range is 120/80 mmHg. Hypertension is diagnosed when blood pressure consistently exceeds this range.

2. What is the difference between stable and unstable angina?

Stable angina occurs with physical exertion and follows a regular pattern, relieved by rest or medication. Unstable angina does not follow a regular pattern, can occur at rest, and is more serious—rest or medication may not relieve it.

3. What is the RAAS system?

The Renin-Angiotensin-Aldosterone System (RAAS) is a hormone system that regulates blood pressure and fluid balance. It involves renin, angiotensinogen, ACE, angiotensin II, and aldosterone.

4. What is the difference between LDL and HDL cholesterol?

LDL (Low-Density Lipoprotein) is “bad cholesterol” that can block arteries. HDL (High-Density Lipoprotein) is “good cholesterol” that transports cholesterol to the liver for elimination.

5. What is the difference between systolic and diastolic heart failure?

Systolic heart failure is a pumping problem—the left ventricle fails to contract vigorously. Diastolic heart failure is a filling problem—the left ventricle fails to relax or fill completely.

6. What are the four stages of heart failure?

The four stages are: Stage A (high risk, no symptoms), Stage B (cardiac changes, no symptoms), Stage C (diminished function, symptoms), and Stage D (persistent symptoms, significant drop in ejection fraction).

SUMMARY

Cardiovascular diseases are the most common cause of death worldwide. This guide covered the major cardiovascular diseases:

• Hypertension: High blood pressure; managed with lifestyle changes, ACE inhibitors, ARBs, CCBs, and diuretics
• Angina Pectoris: Chest pain due to reduced blood flow; managed with nitrates, β-blockers, and CCBs
• Myocardial Infarction: Heart attack; managed with thrombolytics, antiplatelets, and nitroglycerin
• Hyperlipidemia: High cholesterol; managed with statins, ezetimibe, and fibrates
• Congestive Heart Failure: Heart unable to pump enough blood; managed with ACE inhibitors, β-blockers, and diuretics

As I always tell my students: “Cardiovascular diseases are preventable and manageable. Understanding the pathophysiology and pharmacology of these conditions is essential for improving patient outcomes and saving lives.”

REFERENCES AND FURTHER READING

• Pharmacy Council of India (PCI). (2022). Pharmacotherapeutics Syllabus. New Delhi: PCI.
• Rang, H. P., & Dale, M. M. (2021). Rang & Dale’s Pharmacology (9th ed.). Elsevier.
• Goodman, L. S., & Gilman, A. (2018). Goodman & Gilman’s The Pharmacological Basis of Therapeutics (13th ed.). McGraw-Hill.
• Katzung, B. G. (2021). Basic and Clinical Pharmacology (15th ed.). McGraw-Hill.
• World Health Organization (WHO). (2022). Cardiovascular Diseases. Retrieved from https://www.who.int.
• American Heart Association. (2023). Heart Disease and Stroke Statistics. Retrieved from https://www.heart.org.

Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult qualified healthcare professionals for medical concerns. Pharmaceutical regulations and guidelines may vary by region—always refer to your local regulatory authorities for specific requirements.

written by:
Dr. N. Sujith Kumar

Dr. N. Sujith Kumar is a pharmacy educator, Pharm.D graduate, and academic content creator from Jawaharlal Nehru Technological University Kakinada (JNTUK), where he completed his Doctor of Pharmacy (Pharm.D) degree between 2015 and 2021. He has more than 7 years of experience creating pharmacy educational content, writing study materials, and reviewing academic articles for pharmacy students. He has also contributed guest articles to pharmacy education platforms, including PharmD Guru. At D.PharmGuru, his work focuses on simplifying complex Diploma in Pharmacy (D.Pharmacy) subjects into easy-to-understand notes, practical explanations, and exam-oriented educational resources for students across India. His areas of focus include Human Anatomy and Physiology, Pharmaceutics, Pharmacology, Pharmaceutical Chemistry, Hospital and Clinical Pharmacy, and other core D.Pharmacy subjects.

For More Study Materials, Visit: www.dpharmguru.com